NEU 6.41% $15.27 neuren pharmaceuticals limited

Ann: Rett Syndrome NDA accepted for Priority Review by FDA, page-153

  1. 3,447 Posts.
    lightbulb Created with Sketch. 818
    Yeah how about we NOT do that !!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.